CA 108961/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2005	1
2006	2
2007	3
2008	5
2009	1
2010	7
2011	3
2012	2
2013	1
2014	1
2015	1
2024	0

1

Targeting Pyk2 for therapeutic intervention.

Lipinski CA, Loftus JC. Lipinski CA, et al. Expert Opin Ther Targets. 2010 Jan;14(1):95-108. doi: 10.1517/14728220903473194. Expert Opin Ther Targets. 2010. PMID: 20001213 Free PMC article. Review.

2

Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.

Simpson L, Galanis E. Simpson L, et al. Expert Rev Anticancer Ther. 2006 Nov;6(11):1593-607. doi: 10.1586/14737140.6.11.1593. Expert Rev Anticancer Ther. 2006. PMID: 17134364 Review.

3

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells.

Allen C, Opyrchal M, Aderca I, Schroeder MA, Sarkaria JN, Domingo E, Federspiel MJ, Galanis E. Allen C, et al. Gene Ther. 2013 Apr;20(4):444-9. doi: 10.1038/gt.2012.62. Epub 2012 Aug 23. Gene Ther. 2013. PMID: 22914495 Free PMC article.

4

Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatments.

Galanis E, Wu W, Sarkaria J, Chang SM, Colman H, Sargent D, Reardon DA. Galanis E, et al. Curr Oncol Rep. 2011 Feb;13(1):42-9. doi: 10.1007/s11912-010-0144-x. Curr Oncol Rep. 2011. PMID: 21125354 Free PMC article. Review.

5

Oncolytic measles virus strains in the treatment of gliomas.

Allen C, Paraskevakou G, Liu C, Iankov ID, Msaouel P, Zollman P, Myers R, Peng KW, Russell SJ, Galanis E. Allen C, et al. Expert Opin Biol Ther. 2008 Feb;8(2):213-20. doi: 10.1517/14712598.8.2.213. Expert Opin Biol Ther. 2008. PMID: 18194077 Free PMC article. Review.

6

Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.

Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E. Liu C, et al. Clin Cancer Res. 2007 Dec 1;13(23):7155-65. doi: 10.1158/1078-0432.CCR-07-1306. Clin Cancer Res. 2007. PMID: 18056196

7

The Pyk2 FERM regulates Pyk2 complex formation and phosphorylation.

Riggs D, Yang Z, Kloss J, Loftus JC. Riggs D, et al. Cell Signal. 2011 Jan;23(1):288-96. doi: 10.1016/j.cellsig.2010.09.015. Epub 2010 Sep 16. Cell Signal. 2011. PMID: 20849950 Free PMC article.

8

Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.

Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Gastineau DA, Dietz AB. Gustafson MP, et al. Neuro Oncol. 2010 Jul;12(7):631-44. doi: 10.1093/neuonc/noq001. Epub 2010 Feb 23. Neuro Oncol. 2010. PMID: 20179016 Free PMC article.

9

Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts.

Lipinski CA, Tran NL, Viso C, Kloss J, Yang Z, Berens ME, Loftus JC. Lipinski CA, et al. J Neurooncol. 2008 Nov;90(2):181-9. doi: 10.1007/s11060-008-9656-8. Epub 2008 Jul 22. J Neurooncol. 2008. PMID: 18648907 Free PMC article.

10

Critical role of the FERM domain in Pyk2 stimulated glioma cell migration.

Lipinski CA, Tran NL, Dooley A, Pang YP, Rohl C, Kloss J, Yang Z, McDonough W, Craig D, Berens ME, Loftus JC. Lipinski CA, et al. Biochem Biophys Res Commun. 2006 Oct 27;349(3):939-47. doi: 10.1016/j.bbrc.2006.08.134. Epub 2006 Aug 31. Biochem Biophys Res Commun. 2006. PMID: 16962067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year